135 related articles for article (PubMed ID: 1133819)
1. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
Nestor JJ; Ferger MF; du Vigneaud V
J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
[TBL] [Abstract][Full Text] [Related]
2. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
[TBL] [Abstract][Full Text] [Related]
3. (1-Beta-mercaptopropionic acid, 2-(3,5-dibromo-L-tyrosine))oxytocin, a potent inhibitor of oxytocin.
Lundell EO; Ferger MF
J Med Chem; 1975 Oct; 18(10):1045-7. PubMed ID: 1159688
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
Ferger MF; Chan WY
J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679
[TBL] [Abstract][Full Text] [Related]
5. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
Nestor JJ; Ferger MF; Chan WY
J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and some pharmacological properties of [1-beta-mercapto-beta,beta-diethylpropionic acid,2-(3,5-dibromo-L-tyrosine)]oxytocin.
Lundell EO; Smith CW; Ferger MF
J Med Chem; 1975 Dec; 18(12):1262-4. PubMed ID: 1195281
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of three oxytocin analogs related to (1-deaminopenicillamine)oxytocin possessing antioxytocic acitvity.
Vavrek RJ; Ferger MF; Allen GA; Rich DH; Blomquist AT; Du Vigneaud V
J Med Chem; 1972 Feb; 15(2):123-6. PubMed ID: 5008235
[No Abstract] [Full Text] [Related]
8. (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)-8-lysine-vasopressin and (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)oxytocin, compounds possessing antihormonal properties.
Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V; Chan WY
J Med Chem; 1974 Sep; 17(9):969-72. PubMed ID: 4855467
[No Abstract] [Full Text] [Related]
9. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
[TBL] [Abstract][Full Text] [Related]
10. Some pharmacological properties of cyclic and linear analogs obtained by substituting each residue of an oxytocin antagonist with D-tryptophan.
Flouret G; Brieher W; Majewski T; Mahan K; Wilson L
Int J Pept Protein Res; 1991 Aug; 38(2):169-75. PubMed ID: 1783491
[TBL] [Abstract][Full Text] [Related]
11. (1-Beta-mercapto-beta,beta-diethylpropionic acid)-8-lysine-vasopressin, a potent inhibitor of 8-lysine-vasopressin and of oxytocin.
Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V
J Med Chem; 1974 Feb; 17(2):250-2. PubMed ID: 4809260
[No Abstract] [Full Text] [Related]
12. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
Manning M; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
[TBL] [Abstract][Full Text] [Related]
13. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
14. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
Manning M; Lowbridge J; Sawyer WH; Haldar J
J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and some pharmacological properties of (3-beta-(2-thienyl)-L-alanine)-8-lysine-vasopressin.
Smith CW; Ferger MF; Chan WY
J Med Chem; 1975 Aug; 18(8):822-5. PubMed ID: 1171984
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and some pharmacological properties of five analogs of oxytocin having L-homocysteine in position 6.
Smith CW; Ferger MF
J Med Chem; 1976 Feb; 19(2):250-4. PubMed ID: 1249804
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and some pharmacological properties of oxytocin analogues having L-thiazolidine-4-carboxylic acid in position 7.
Rosamond JD; Ferger MF
J Med Chem; 1976 Jul; 19(7):873-6. PubMed ID: 940106
[TBL] [Abstract][Full Text] [Related]
19. Synthetic antagonists of in vivo responses by the rat uterus to oxytocin.
Lowbridge J; Manning M; Seto J; Haldar J; Sawyer WH
J Med Chem; 1979 May; 22(5):565-9. PubMed ID: 458806
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of (1-(L-2-hydroxy-3-mercaptopropanoic acid))oxytocin, a highly potent analogue of oxytocin.
Wälti M; Hope DB
J Chem Soc Perkin 1; 1972; 15():1946-50. PubMed ID: 4672381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
